[1]
Sivagourounadin, K., Subbiah, V., Krishnasamy, G. and Rajendran, P. 2020. A study on haloperidol and risperidone induced metabolic derangements in patients with newly diagnosed schizophrenia. International Journal of Basic & Clinical Pharmacology. 9, 2 (Jan. 2020), 282–288. DOI:https://doi.org/10.18203/2319-2003.ijbcp20200177.